T-cell activity was evaluated by isolating tumor-specific CD8+ T-cells and measuring the production of cytokines (IFN-γ and IL-2) by CD8+ and CD4+ T-cells challenged with MCPyV peptides [195]. The gene discussed is CD8A; the disease is neoplasm.